Skip to content

Distant Management of Crohn's Disease by Smartphones is Feasible and Effective Additionally it Reduces the Costs

Implementation and Evaluation of Smartphone-Based Videoconferance Telehealth for Patients With Crohn's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04754620
Enrollment
139
Registered
2021-02-15
Start date
2020-03-01
Completion date
2020-09-01
Last updated
2021-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease

Brief summary

Evaluation of the feasibility, acceptability, patient satisfaction and economic benefits of smartphone video-based telehealth in the management of Crohn's disease patients

Detailed description

Patients were examined by two gastroenterologists (HY, AED) either at a video conference based visit or face to face visit in outpatients clinics. We used the WhatsApp business application.The online visit notion was the same as traditional face-to-face visit except physical examination.

Interventions

OTHERreal time online video visit

Participants have received an online visit by a smartphone application

Sponsors

Kocaeli University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The study group included patients with documented Crohn's disease, based on clinical, endoscopic, and histologic findings * Patient between 18-80 years old * Participants who have been receiving treatment for more than six months

Exclusion criteria

* Patients were excluded from the study if they had no internet connection * Unable to use smartphones because of blindness, deafness, or mental disorders

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction score with the video visitsthe day after the visitMeasurement of satisfaction with RAND Visit Specific Questionnaire (VSQ9),Minimum score 0 poor and maximum score is 5 represents excellent,

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026